Welcome Apollo and I'm sure there are many others on this board that have been anonymous. It is absolutely necessary to have as many of us comment here about the poor job of shareholder relations. I am determined to force them to come to the realization that it is detrimental to the future of this company to ignore its shareholders. I've said it many times that I have put my money where my mouth is, and I have no quams about calling BioCurex. None of us would be here or hold onto one share of this stock if we didn't believe in the technology.
I would suggest you go back quite a ways in our posts and you will reveal the answers to many of your questions. I only say this for fear of repeating myself, but in summary, for the most part, most longs are 2 thumbs up on the technology and 2 thumbs down on management. We hope that the technology will be approved shortly after Abbott or Inverness get thru whatever trials are necessary. Then we will be rewarded by a significant move in the share price. We will move higher in the interim only if we are given an update. The only one that is selling is the hedge fund that is doing their best to keep us under .70 cents for some reason.
As far as what the share price will be is only speculation. If you ask anyone on this board, though, they would tell you that this is probably a opportunity worth the risk.
